Fosinopril-impurities | Pharmaffiliates

fosinopril

An angiotensin converting enzyme (ACE) inhibitor, Fosinopril is used for the treatment of hypertension and heart failure. It is a prodrug and is converted in vivo to the active form fosinoprilat. Reference standards of Fosinopril API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Fosinopril - API Standards 
    [catalogue_number] => PA 06 46000
    [category_ids] => ,72,92,80,
    [chemical_name] => 
    [weight] => 563.66
    [form] => C30H46NO7P
    [cas] => 98048-97-6
    [pslug] => 98048-97-6-fosinopril-api-pa0646000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 06 46000

Fosinopril - API Standards


  • Catalogue No.:PA 06 46000

  • CAS :

    98048-97-6

  • Molecular Formula : C30H46NO7P

  • Molecular Weight : 563.66

stdClass Object
(
    [pname] => ((4-Phenylbutyl)phosphinyl acetic acid, Disodium Salt)
    [catalogue_number] => PA 06 47070
    [category_ids] => ,80,92,72,
    [chemical_name] => 
    [weight] => 300.2
    [form] => C12H15Na2O4P
    [cas] => NA
    [pslug] => 4-phenylbutyl-phosphinyl-acetic-acid-disodium-salt-pa0647070
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 06 47070

((4-Phenylbutyl)phosphinyl acetic acid, Disodium Salt)


  • Catalogue No.:PA 06 47070

  • CAS :

    NA

  • Molecular Formula : C12H15Na2O4P

  • Molecular Weight : 300.2